跳至主要内容
欧盟官方标签名称词汇表条目 8735

DIHYDROXYINDOLINE

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 7 个有匹配的监管证据:8 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。

7 个市场有证据
已检查的市场
13
有证据的市场
7
证据缺口
6
已解析的标识符
3

已解析的物质身份

CAS:29539-03-5138937-28-7
EC:421-170-6
成分索引记录:
DIHYDROXYINDOLINE
化妆品功能: HAIR DYEING

2,3-Dihydro-1H-Indole-5,6-Diol; 5,6-Indolinediol

清单限制备注: III/204

DIHYDROXYINDOLINE HBR
化妆品功能: HAIR DYEING

2,3-Dihydro-1H-Indole-5,6-Diol Hydrobromide

清单限制备注: III/204

9 个匹配或报告的名称
DIHYDROXYINDOLINEDIHYDROXYINDOLINE HBR2,3-Dihydro-1H-indole-5,6-diol and its hydrobromide salt (see note 17).Dihydroxy indolineDihydroxy indoline HBr2,3-Dihydro-1H-indole-5,6-diol and its hydrobromide salt* (dihydroxyindoline; dihydroxyindoline HBr)2,3-Dihydro-1H-indole-5,6-diol and its hydrobromide salt Dihydroxyindoline CAS No 29539-03-5 Dihydroxyindoline HBr CAS No 138937-28-72,3-디하이드로-1H-인돌-5,6-디올 (디하이드록시인돌린) 및 그 하이드로브로마이드염 (디하이드록시인돌린 하이드로브롬마이드)1)2,3-디하이드로-1H-인돌-5,6-디올(디하이드록시인돌린) 및 그 하이드로브로마이드염2,3-Dihydro-1H-indole 5,6- diol and its hydrobromide 15 salt ( ) Dihydroxyindoline (CAS 29539-03-5) Dihydroxyindoline HBr (CAS 138937-28-7)

全部 13 个市场的监管证据

打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。

滑动或横向滚动以查看数据集覆盖范围和后续操作。

市场结果记录数据集含义 / 后续操作
European Union
EU
限用1打开记录 1
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
请查看每条关联记录及其确切条件。
Great Britain
GB
Restricted1打开记录 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
请查看每条关联记录及其确切条件。
Canada
CA
未找到匹配项0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
Restricted2打开记录 1打开记录 2
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
请查看每条关联记录及其确切条件。
ASEAN
ASEAN
Restricted1打开记录 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
请查看每条关联记录及其确切条件。
China
CN
未找到匹配项0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Prohibited2打开记录 1打开记录 2
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
请查看每条关联记录及其确切条件。
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
未找到匹配项0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
Restricted1打开记录 1
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
请查看每条关联记录及其确切条件。
Saudi Arabia
SA
Restricted1打开记录 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
请查看每条关联记录及其确切条件。
没有与此筛选条件匹配的市场行。

匹配的市场记录和条件

附件 II–VI 的精确证据

Annex III条目 204
打开完整监管记录

DIHYDROXYINDOLINE

产品范围: Hair dye substance in non-oxidative hair dye products

最大浓度: 2.0%

警示语: - Can cause allergic reaction - You have ever experienced any reaction afther colouring your hair - You have experienced a reaction to a temporary 'black henna' tattoo in the past

化学身份与性质

CAS 138937-28-7 的 PubChem 二维化学结构
CAS 138937-28-7PubChem CID 22020437

5,6-Dihydroxyindoline hydrobromide

IUPAC 名称
2,3-dihydro-1H-indole-5,6-diol;hydrobromide
分子式
C8H10BrNO2
分子量
232.07 g/mol
精确质量
230.98949 Da
拓扑极性表面积
52.5 Ų
氢键供体
4
氢键受体
3
共价单元
2
已定义的立体中心
0

又称

RefChem:5280725,6-Dihydroxy-2,3-dihydro-1H-indolium bromideEC 421-170-6Indoline-5,6-diol hydrobromide5,6-DIHYDROXYINDOLINE HBRDIHYDROXYINDOLINE HBRAS-173475,6-DihydroxyindolineHBr
另有 6 个已报告名称
Indoline-5,6-dIndoline-5,6-diol HBrIndoline-5,6-diolhydrobromideindoline-5,6-diol;hydrobromideCS-0209156FT-0654053
外部数据库标识符

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 29539-03-5 的 PubChem 二维化学结构
CAS 29539-03-5PubChem CID 147311

5,6-Dihydroxyindoline

Leukoaminochrome is a member of the class of indoles that is indoline with hydroxy substituents at positions 5 and 6. It has a role as a metabolite. It is a member of indoles and a member of catechols. It derives from a hydride of an indoline. — ChEBI

IUPAC 名称
2,3-dihydro-1H-indole-5,6-diol
分子式
C8H9NO2
分子量
151.16 g/mol
精确质量
151.063328530 Da
XLogP3
1.2
拓扑极性表面积
52.5 Ų
氢键供体
3
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

Indoline-5,6-diol5,6-IndolinediolLeukoaminochromeHH49N58FJ9CHEBI:74683RefChem:10722011H-Indole-5,6-diol, 2,3-dihydro-56DHInn
另有 9 个已报告名称
2-descarboxy-cyclo-dopa2,3-Dihydro-5,6-dihydroxyindole5,6-Dihydroxy-2,3-dihydroindoleLeucoaminochromeLEUCODOPAMINOCHROMEUNII-HH49N58FJ9VGSVNUGKHOVSPK-UHFFFAOYSA-NAC-27802CS-0343102
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定